KLRK1 抗体
-
- 抗原 See all KLRK1 抗体
- KLRK1 (Killer Cell Lectin-Like Receptor Subfamily K, Member 1 (KLRK1))
-
适用
- 人
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This KLRK1 antibody is un-conjugated
-
应用范围
- Flow Cytometry (FACS), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunohistochemistry (Frozen Sections) (IHC (fro)), Functional Studies (Func)
- 特异性
- Recognizes human CD314. Reported to inhibit T cell recognition of MICA (1,6).
- 纯化方法
- Protein G purified
- 内毒素水平
- Low Endotoxin
- 免疫原
- NKL cells.
- 克隆位点
- 1D11
- 亚型
- IgG1
- Top Product
- Discover our top product KLRK1 Primary Antibody
-
-
- 应用备注
-
Approved: Flo (1:50 - 1:200), Func, IHC, IHC-Fr, IP
Usage: Suitable for use in Flow Cytometry, Functional Assays, Immunohistochemistry (frozen), and Immunoprecipitation. Flow Cytometry: 1:50-1:200, 10 μL labels 10^6 cells in 100 μL. - 说明
-
Target Species of Antibody: Human
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- Lot specific
- 缓冲液
- PBS, pH 7.4. No preservatives added
- 储存液
- Without preservative
- 注意事项
- Avoid repeated freezing and thawing
- 储存条件
- 4 °C,-20 °C
- 储存方法
- May be stored at 4°C for short-term only. For long-term storage and to avoid freeze-thaw cycles, aliquot and store at -20°C. Aliquots are stable for at least 1 year at -20°C.
-
- 抗原
- KLRK1 (Killer Cell Lectin-Like Receptor Subfamily K, Member 1 (KLRK1))
- 别名
- KLRK1 / CD314 / NKG2D (KLRK1 产品)
- 别名
- KLRK1 antibody, NKG2D antibody, CD314 antibody, D12S2489E antibody, KLR antibody, NKG2-D antibody, D6H12S2489E antibody, Nkg2d antibody, Nkrp2 antibody, killer cell lectin like receptor K1 antibody, killer cell lectin-like receptor subfamily K, member 1 antibody, NKG2D protein antibody, KLRK1 antibody, Klrk1 antibody, NKG2D antibody
- 背景
-
Name/Gene ID: KLRK1
Synonyms: KLRK1, D12S2489E, CD314 antigen, KLR, NK cell receptor D, NKG2D, NKG2-D, NKG2-D-activating NK receptor, CD314 - 基因ID
- 22914
- UniProt
- P26718
- 途径
- Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
-